Cardiac Drugs Flashcards
Major risk factors for increased perioperative CV risk
Unstable Coronary Syndromes
Decompensated Heart Failure
Significant Arrhythmias
Severe Valvular disease
Intermediate risk factors for increased perioperative CV risk
Mild angina Previous MI Compensated/previous heart failure DM (esp insulin dependent) Renal insufficiency
Minor risk factors for increased perioperative CV risk
Advanced age Abnormal ECG (LVH, LBBB, ST abnormalities) Rhythm other than NSR Low functional capacity History of smoking Uncontrolled systemic hypertension
Perioperative cardiac risk reduction strategies
Many have conflicting results as to if they are effective or not
Beta blockers show evidence for effectiveness in vascular surgery
Statins show evidence for effectiveness
Preop coronary revascularization shows conflicting evidence
Perioperative monitoring (PA, CVP, TEE) hasn’t shown to be effective
Classes of Antiarrhythmic drugs and what they do
I: Block Na channels
II: Beta-adrenergic blocking effects
III: Blocks K channels
IV: Blocks Ca channels
Common class I antiarrhythmic drugs and what they’re used for
Lidocaine, procainamide, phenytoin
Used for ventricular arrhythmias
-Blocks Na channels (Na channels cause ventricular depolarization)
Common class III antiarrhythmic drugs and what they’re used for
Amiodarone, sotalol
Prolongs repolarization
-Blocks K channels
Common class IV antiarrhythmic drugs and what they’re used for
Verapamil, diltiazem
Used for Atrial arrhythmias
-Blocks Ca channels (SA/AV depolarization caused by Ca channels)
1st line therapy for managing A fib
Ventricular rate control (<110bpm)
-Use beta blockers or calcium channel blockers
When to avoid beta blocker use
COPD or asthma patients
-Cause bronchoconstriction
Where and how does adenosine work
Purine (purinergic) receptors
Slows sinoatrial and atrioventricular nodal conduction
Inhibits the AV node
-Opens K channels (hyperpolarize), indirectly inhibits calcium channels from opening
SVT management in the OR
Won’t do adenosine (cause asystole)
Calcium channel blockers: Verapamil or diltiazem
V Tach management in the OR
Amiodarone or lidocaine
Contraindication for antiarrhythmic drugs
Heart block
-Many of the antiarrhythmic drugs slow AV conduction
Hypertensive Urgency vs Emergency
Urgency: Isn’t associated with end organ damage, need to get BP down in 24 hours, can use PO meds
Emergency: Presence of acute end organ damage, requires immediate therapy
Mechanism of action of ACEI and ARBs (and normal process)
Normal process:
-Catecholamine release, bind to beta 1 receptors in the kidney
-Renin is released, attaches to receptor and converts Angiotensinogen to Angiotensin 1
-ACE converts Angiotensin 1 to 2 (also breaks down bradykinin)
-Angiotensin 2 binds to receptors to conserve Na and cause vasoconstriction (=Increased BP, augments the autonomic nervous system)
ACEI: Stop conversion of Angiotensin 1 to 2, and the breakdown of bradykinin (=cough)
ARBs: Block Angiotensin 2 from binding to receptors (doesn’t cause cough like ACEI but similar effect, more expensive)
Nipride metabolism (and original molecule components)
Composed of 5 cyanide molecules (toxic) surrounding a nitric oxide molecule
Metabolism
-By hemoglobin, steels an electron, makes nipride unstable, breaks open
-Some cyanide attaches to hgb to be eliminated later, most goes to cyanide pool
-Cyanide pool reacts with thiosulfate (vitamin B12) in the liver, facilitated by enzyme rhodanese, and is excreted in urine
-If cyanide pool>vit B12 available, excess cyanide blocks cytochrome oxidase which is the enzyme that lets the cells use O2
-Cells then can’t burn O2, patient gets histotoxic hypoxia
Recognizing the signs of nipride toxicity
Patients turn pink, their venous blood appears like arterial because they can’t use O2
- VBGs will show very high O2 levels
- Patients will be acidotic because they are producing lactic acid
- Central nervous system dysfunction
- CV instability
What causes rebound hypertension after stopping nipride
Renin release
Labetalol (receptors/effect, onset, half life, dose)
Beta blocker with alpha blocking activity
-B1 activity in the heart to decrease contractility and HR but alpha blocking capability in blood vessels causes vasodilation
Onset: 5-10 minutes
Half life: 3-6 hours
Dose: In OR- 5mg increments
Best drug to use when patients are hypertensive and tachycardic
Esmolol (receptors/effect, onset, half life)
Beta blocker (Cardioselective per pharmaceutical companies but not really in practice)
-Causes decreased cardiac contractility/HR but vasoconstriction
Onset: 1-2 minutes
Half life: 10-30 minutes (metabolized by nonspecific esterase’s)
Best to use for tachycardia control